Home/Filings/4/0001213900-25-123625
4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-25-123625

CIK 0001728328other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 11:39 AM ET

Size

5.4 KB

Accession

0001213900-25-123625

Insider Transaction Report

Form 4
Period: 2025-12-19
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-12-19+35,00049,050 total
    Exercise: $1.29Exp: 2030-12-18Common shares (35,000 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817882

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 11:39 AM ET
Size
5.4 KB